Evaluation of Machine Learning Methods Developed for Prediction of Diabetes Complications: A Systematic Review

Author:

Tan Kuo Ren1ORCID,Seng Jun Jie Benjamin2ORCID,Kwan Yu Heng234ORCID,Chen Ying Jie5ORCID,Zainudin Sueziani Binte6ORCID,Loh Dionne Hui Fang7ORCID,Liu Nan389ORCID,Low Lian Leng71011ORCID

Affiliation:

1. Duke-NUS Medical School, Singapore

2. MOH Holdings Private Ltd., Singapore

3. Health Services & Systems Research, Duke-NUS Medical School, Singapore

4. Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore

5. Nanyang Technological University, Singapore

6. Endocrinology Service, Department of General Medicine, Sengkang General Hospital, Singapore

7. SingHealth Regional Health System, Singapore Health Services, Singapore

8. Health Services Research Centre, Singapore Health Services, Singapore

9. Institute of Data Science, National University of Singapore, Singapore

10. Department of Family Medicine and Continuing Care, Singapore General Hospital, Singapore

11. SingHealth Duke-NUS Family Medicine Academic Clinical Program, SingHealth Duke-NUS Academic Medical Centre, Singapore

Abstract

Background: With the rising prevalence of diabetes, machine learning (ML) models have been increasingly used for prediction of diabetes and its complications, due to their ability to handle large complex data sets. This study aims to evaluate the quality and performance of ML models developed to predict microvascular and macrovascular diabetes complications in an adult Type 2 diabetes population. Methods: A systematic review was conducted in MEDLINE®, Embase®, the Cochrane® Library, Web of Science®, and DBLP Computer Science Bibliography databases according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist. Studies that developed or validated ML prediction models for microvascular or macrovascular complications in people with Type 2 diabetes were included. Prediction performance was evaluated using area under the receiver operating characteristic curve (AUC). An AUC >0.75 indicates clearly useful discrimination performance, while a positive mean relative AUC difference indicates better comparative model performance. Results: Of 13 606 articles screened, 32 studies comprising 87 ML models were included. Neural networks (n = 15) were the most frequently utilized. Age, duration of diabetes, and body mass index were common predictors in ML models. Across predicted outcomes, 36% of the models demonstrated clearly useful discrimination. Most ML models reported positive mean relative AUC compared with non-ML methods, with random forest showing the best overall performance for microvascular and macrovascular outcomes. Majority (n = 31) of studies had high risk of bias. Conclusions: Random forest was found to have the overall best prediction performance. Current ML prediction models remain largely exploratory, and external validation studies are required before their clinical implementation. Protocol Registration: Open Science Framework (registration number: 10.17605/OSF.IO/UP49X).

Funder

ministry of health singapore

SingHealth Duke-NUS Academic Medical Centre

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3